Zhou, Y., & Jeanne Kreek, M. (2019). Clinically utilized kappa-opioid receptor agonist nalfurafine combined with low-dose naltrexone prevents alcohol relapse-like drinking in male and female mice. Brain Res.
Trích dẫn kiểu ChicagoZhou, Yan, và Mary Jeanne Kreek. "Clinically Utilized Kappa-opioid Receptor Agonist Nalfurafine Combined With Low-dose Naltrexone Prevents Alcohol Relapse-like Drinking in Male and Female Mice." Brain Res 2019.
Trích dẫn MLAZhou, Yan, và Mary Jeanne Kreek. "Clinically Utilized Kappa-opioid Receptor Agonist Nalfurafine Combined With Low-dose Naltrexone Prevents Alcohol Relapse-like Drinking in Male and Female Mice." Brain Res 2019.
Cảnh báo: Các trích dẫn này có thể không phải lúc nào cũng chính xác 100%.